Literature DB >> 28953089

Lawsuits After Primary and Revision Total Knee Arthroplasty: A Malpractice Claims Analysis.

Diana C Patterson1, Ronald Grelsamer, Michael J Bronson, Calin S Moucha.   

Abstract

INTRODUCTION: As the number of total knee arthroplasties (TKAs) increases, the number of associated complications will also increase. Our goal with this study was to identify common causes of and financial trends relating to malpractice claims filed after TKA.
METHODS: We analyzed malpractice claims filed for alleged neglectful primary and revision TKA surgeries performed between 1982 and 2012 by orthopaedic surgeons insured by a large New York state malpractice carrier.
RESULTS: We identified 69 primary and 8 revision TKAs in the malpractice carrier's database. All cases were performed between 1982 and 2012; all claims were closed between 1989-2015. The most frequent factor leading to lawsuits for primary TKA was chronic pain or dissatisfaction in 12 cases, followed by nerve palsy in 8, postoperative in-hospital falls in 5, and deep vein thrombosis or pulmonary embolism in 3. Medical complications included acute respiratory distress syndrome, cardiac arrest, and decubitus ulcers. Contracture was most common after revision TKA (three of eight cases). Mean indemnity was $325,369, and the largest single settlement was $2.42 million. The average expense relating to the defense of these cases was $66,365.
CONCLUSIONS: Orthopaedic surgeons should continue to focus attention on prevention of complications and on preoperative patient education. Preoperative counseling regarding the risks of incomplete pain relief could reduce substantially the number of suits relating to primary TKAs.

Entities:  

Mesh:

Year:  2017        PMID: 28953089     DOI: 10.5435/JAAOS-D-16-00736

Source DB:  PubMed          Journal:  J Am Acad Orthop Surg        ISSN: 1067-151X            Impact factor:   3.020


  8 in total

1.  Unaddressed arterial injuries in revision total hip arthroplasty: mortality outcomes of a low-prevalence complication.

Authors:  Pablo Ariel Slullitel; Lionel Llano; Christian García-Ávila; Fernando Diaz-Dilernia; Francisco Piccaluga; Martin Buttaro; Gerardo Zanotti; Fernando Comba
Journal:  Int Orthop       Date:  2019-06-20       Impact factor: 3.075

2.  Clinical spectrum of neuropathy after primary total knee arthroplasty: A series of 54 cases.

Authors:  Scott J A Speelziek; Nathan P Staff; Rebecca L Johnson; Rafael J Sierra; Ruple S Laughlin
Journal:  Muscle Nerve       Date:  2019-04-04       Impact factor: 3.217

3.  Claims in total hip arthroplasty: analysis of the instigating factors, costs and possible solution.

Authors:  M Novi; C Vanni; P D Parchi; M Di Paolo; N Piolanti; M Scaglione
Journal:  Musculoskelet Surg       Date:  2019-02-13

4.  Delayed Diagnosis Is the Primary Cause of Sarcoma Litigation: Analysis of Malpractice Claims in the United States.

Authors:  Richard Hwang; Howard Y Park; William Sheppard; Nicholas M Bernthal
Journal:  Clin Orthop Relat Res       Date:  2020-10       Impact factor: 4.755

5.  Claims in orthopedic foot/ankle surgery, how can they help to improve quality of care? A retrospective claim analysis.

Authors:  Fay R K Sanders; Patricia Wimmer-Boelhouwers; Onno X Dijt; Gino M M J Kerkhoffs; Tim Schepers
Journal:  Eur J Orthop Surg Traumatol       Date:  2020-07-26

6.  Analysis of Judicial Precedents Cases Regarding Skin Cancer from 1997 to 2017 in Republic of Korea.

Authors:  Su Hwan Shin; Won Lee; So Yoon Kim; Gwanghyun Jo; Je-Ho Mun; Soo Ick Cho
Journal:  Ann Dermatol       Date:  2019-05-01       Impact factor: 1.444

7.  Litigation analysis of medical damage after total knee arthroplasty: a case study based on Chinese legal database in the past ten years.

Authors:  Shuai Liu; Jilong Zou; Shuai Wang; Guangyu Liu; Yan Zhang; Shuo Geng
Journal:  Arthroplasty       Date:  2022-10-01

8.  A Vertical Measurement System to Predict the Change in Leg Length in Total Hip Arthroplasty.

Authors:  Garth Grobler; Marc Nortje; Brendan Dower; Dave Chivers
Journal:  Arthroplast Today       Date:  2020-06-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.